Loading...
Loading...

Services to Guide You

Choose your starting point within the product development life cycle to learn how we can support your team with immediate solutions on your path to healthcare access. Or access the IP Illuminator™, our proprietary strategy building tool, to develop a customized plan tailored to your specific needs and interests  – targeting your long-term success across your product’s development, through commercialization, and beyond.

VIEW ALL OUR SERVICES

PRE-CLINICAL

PHASE 1

PHASE 2

PHASE 3

REGULATORY REVIEW

POST APPROVAL & MARKETING

Build a Custom Strategy

Access the IP Illuminator™, our proprietary strategy building tool, to develop a customized plan of strategic solutions IP can offer to meet your unique needs.

Start Building

Proven Process, Expertise, and Influential Relationships

Innovation Partners’ proven process leverages influential and wide-reaching relationships, extensive experience, and deep expertise within the oncology, hematology, and rare disease markets. We simplify the complex and provide actionable insights to help manufacturers gain access for their innovations.

45+ Brand Launches

Supporting strategy development and broad access for patients, providers, and payers.

150+ Completed Projects

Across market access, market research, and medical affairs expertise.

Access to Clinical Experts

Across various therapeutic specialties including physicians, pathologists, pharmacists, and nurses.

Access to Payer Decision Makers

Including pharmacy and medical directors at large and regional health plans, IDNs, PBMs, and Trade & Distribution Organizations.

Global Reach

Across North America, Latin America, Europe, Africa, Asia, and the Western Pacific.

Proven Process, Expertise, and Influential Relationships

Innovation Partners’ proven process leverages influential and wide-reaching relationships, extensive experience, and deep expertise within the oncology, hematology, and rare disease markets. We simplify the complex and provide actionable insights to help manufacturers gain access to their innovations.

45+ Brand Launches

Supporting strategy development and broad access for patients, providers, and payers.

150+ Completed Projects

Across market access, market research, and medical affairs expertise.

Access to Clinical Experts

Across various therapeutic specialties including physicians, pathologists, pharmacists, and nurses.

Access to Payer Decision Makers

Including pharmacy and medical directors at large and regional health plans, IDNs, PBMs, and Trade & Distribution Organizations.

Global Reach

Across North America, Latin America, Europe, Africa, Asia, and the Western Pacific.

Dedicated to Success

We have helped more than 50 clients to achieve healthcare access through market access, medical affairs and market research solutions. Of IP clients surveyed, 100% report they are “extremely likely” to use IP services again.

Client Testimonials

Being a UK company, new to the US market, trying to navigate the reimbursement landscape felt impossible. IP have supported us through this and continue to be a fantastic partner.
CEO, Medical Device Company
We were facing a knowledge gap. Most consultants only focus on one [perspective], where IP can get all perspectives and report back from all angles. From a credibility standpoint, I knew IP would do nothing but enhance our value.
Sr. Director, National Accounts, Pharma/Biotech Company
The IP team are great partners. They are very knowledgeable and easy to work with. They are solutions oriented.
VP, Market Access, Pharma/Biotech Company
We engaged IP to help us identify KOLs in areas which our team didn’t have the level of comfort that we needed at the time, specifically Hematologists in Europe. Their execution was flawless.
Medical Director, Pharma/Biotech Company
When you work with larger agencies, you can lose that personal touch. The IP team offers hand-delivered service you don’t get with other companies.
Medical Director, Pharma/Biotech Company

We love IP!

Director, US Market Access Launch Lead, Pharma/Biotech Company
We are pioneering a new paradigm in oncology…so we needed to gain early insights from decision makers at leading payers, GPOs and pharmacists to help inform our strategic positioning and planning. The IP team got us to the right people quickly and we gained meaningful and actionable insights that have driven value in our organization.
CEO, Pharma/Biotech Company
The IP team is client focused and easy to work with. They are also flexible and efficient and stay on track with deliverables and timelines. The final work product is of high quality and is in a usable format.
CEO, Pharma/Biotech Company

IP is highly client focused and provides cost-effective, tailored solutions to what a company actually needs.

CEO, Pharma/Biotech Company

IP have continued to be critical in our US strategy. From day one they have worked closely with [us] as an extended part of our company, understanding our challenges and working with us to find solutions putting a clear strategy in place and ultimately delivering on their word. Our relationship is incredibly strong and they feel like family.

CEO, Medical Device Company
IP have continued to be critical in our US strategy. From day one they have worked closely with [us] as an extended part of our company, understanding our challenges and working with us to find solutions putting a clear strategy in place and ultimately delivering on their word. Our relationship is incredibly strong and they feel like family.
CEO, Pharma/Biotech Company
[IP has] a huge amount of experience and connections in the industry but what I love about them is that they are honest, supportive and ultimately want us to succeed.

CEO, Medical Device Company
[What sets IP apart is] Knowledge of the oncology market and relationships with key players
VP, Market Access, Pharma/Biotech Company

Stakeholder Testimonials

I have had very positive experiences with IP. They have assisted many industry partners in their early development process. They have introduced these organizations to professional organizations in efforts to understand missions, programs, and opportunities for support. They are great to work with and always very responsive.

Vice President, Clinical Compendia Organization
IP is a very professional, well prepared and knowledgeable company to work with. They are on the cutting edge of drug information and technology.
Director of Pharmacy, Integrated Delivery Network
IP brings the best minds together on issues of the day. Very open to collaboration.
Tim Paine, VP, Pharma Strategy and Relations, Fairview Pharmacy Services
Innovation Partners is very engaged with their partners. [There is a] lot of follow up on specific issues.
Jack Erter, MD, Tennessee Oncology, PLLC
Very good relationships [sets IP apart]. [They engage on] good topics and the interviewers stay on time.
Dan Kus, VP, Pharmacy Services, Henry Ford Health System
IP displays the most current knowledge and insights in today’s specialty pharmacy marketplace. They have been invaluable partners to work with and are always focused on the customer, honest feedback, and integrity.
Clinical Operations Manager, Sutter Health
IP has expertise across the hematology & oncology spectrum.
VP, Specialty Contracting & Management, Henry Ford Health System
IP is knowledgeable and trustworthy.
National Medical Director, Humana

Case Studies

The Challenge

The Challenge

The IP Solution

The IP Solution

The Result

The Results

Our Client Success Stories

View All

Recent Case Studies

Healthcare policy changes interpreted in real-time

A European-based pharmaceutical company with several products in the US market was under pressure to interpret and respond to rapidly changing US healthcare policies which could potentially impact access for their portfolio of oncology products.

A comprehensive launch strategy leads to broad access

A biopharmaceutical company was in the midst of bringing its first product to market with breakthrough therapy designation. The PDUFA date was fast approaching, and their small team needed guidance to steer them through the complicated access and reimbursement landscape.

Understanding the European Market

A mid-sized pharmaceutical company was looking to enter the European market through a compassionate use/early access pathway but lacked an understanding of the requirements specific to each country that would lead to broad access and reimbursement for their product across Europe.